Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Why Is Vera Therapeutics Stock Gaining Tuesday?
↗
July 07, 2026
Via
Benzinga
Exposures
Product Safety
Here's Why Agios Pharmaceuticals Stock Soared Today (Hint: It's FDA-Related)
↗
July 07, 2026
Via
The Motley Fool
Tickers
AGIO
Exposures
Product Safety
Compass Pathways Highlights Long-Term Data from Resistant Depression, Backs 2027 Launch Timeline
↗
July 07, 2026
Via
Benzinga
Exposures
Product Safety
FDA Advisory Panel to Assess Peptide Bulk Drug Substances from Obesity to Opioid
↗
July 07, 2026
Via
Benzinga
Exposures
Product Safety
Why This Novo Nordisk Rival Just Soared Near A Profit-Taking Zone
↗
July 07, 2026
Via
Investor's Business Daily
Exposures
Product Safety
United Health Products Establishes Collaboration to Conduct Clinical Study
July 07, 2026
Via
NewMediaWire
Tickers
UEEC
Exposures
Product Safety
United Health Products Establishes Collaboration to Conduct Clinical Study
July 07, 2026
Via
TheNewswire.com
Tickers
UEEC
Exposures
Product Safety
CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026?
↗
July 07, 2026
Via
The Motley Fool
Tickers
CRSP
VKTX
Exposures
Product Safety
Data Center Disputes Fuel 33 Recall Efforts, Ballotpedia Finds
July 07, 2026
Via
Newsfile
Topics
Artificial Intelligence
Product Recall
Exposures
Artificial Intelligence
COVID-19
Legal
Ford Issues Two Mustang Recalls Covering More Than 110,000 Vehicles as Safety Woes Persist in 2026
↗
July 07, 2026
Via
Benzinga
Topics
Product Recall
Tickers
F
Exposures
Legal
Product Safety
Global Karl Fischer Reagents Market to Reach USD 1.08 Billion by 2034 at 4.4% CAGR
↗
July 07, 2026
Via
Talk Markets
Exposures
Product Safety
Moderna Stock Is Soaring. Is It Too Late to Buy?
↗
July 07, 2026
Via
The Motley Fool
Tickers
MRNA
Exposures
COVID-19
Product Safety
Global Food Additives Market to Reach USD 70.1 Billion by 2034 at 5.0% CAGR
↗
July 07, 2026
Via
Talk Markets
Exposures
Product Safety
Hospira Brand Bacteriostatic Water: Uses, Safety, and Clinical Guidelines
↗
July 07, 2026
Via
Talk Markets
Tickers
PFE
Exposures
Product Safety
Navigating Global Regulations: How GoCompliance is Simplifying Product and Environmental Compliance
July 06, 2026
Via
Press Release Distribution Service
Topics
Artificial Intelligence
Climate Change
Economy
Exposures
Artificial Intelligence
Climate
Legal
FDA Classifies Insulet Omnipod Recall as Serious After Injury Reports
↗
July 06, 2026
Via
Benzinga
Exposures
Product Safety
What's Going on with Vera Therapeutics Stock on Monday?
↗
July 06, 2026
Via
Benzinga
Exposures
Product Safety
Why This Biotech, Up 14% Since Its Breakout, Is On The Rise Once Again
↗
July 06, 2026
Via
Investor's Business Daily
Exposures
Product Safety
OS Therapies Third Quarter 2026 Corporate Outlook
July 06, 2026
Via
Newsfile
Tickers
OSTX
Exposures
Product Safety
Global Ultra-Pure Organic Materials Market to Reach USD 300 Million by 2034 at 8.0% CAGR
↗
July 06, 2026
Via
Talk Markets
Topics
Supply Chain
Exposures
Product Safety
Supply Chain
Zoetis Inc. (ZTS) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit
July 05, 2026
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
ZTS
Exposures
Financial
Legal
Product Safety
Zoetis Inc. (ZTS) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit
July 05, 2026
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
ZTS
Exposures
Financial
Legal
Product Safety
Roseville Estate Planning Attorney Rachel Patton on Making a Daunting Process Feel Human
July 05, 2026
Via
Press Release Distribution Service
Topics
Product Recall
Exposures
Legal
Product Safety
IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors?
↗
July 05, 2026
Via
The Motley Fool
Topics
ETFs
Intellectual Property
Tickers
IHE
IVZ
LLY
PJP
Exposures
Intellectual Property
Product Safety
Natural L-Ergothioneine Market Set for Robust Growth Amid Antioxidant Demand
↗
July 04, 2026
Via
Talk Markets
Exposures
Product Safety
EXCLUSIVE: Reddit Hosted 8 Mock Earnings Calls Before IPO – ‘Acted Like A Public Company’
↗
July 03, 2026
Via
Benzinga
Topics
Initial Public Offering
Product Recall
Tickers
RDDT
Exposures
Legal
Product Safety
Securities Market
MOTS-c is having its biggest month yet: California Trim Clinic breaks down the new human trial and FDA review putting the mitochondrial peptide in the spotlight
July 03, 2026
Via
PRUnderground
Exposures
Product Safety
Moderna Is Up More Than 70% in a Month After a 9-0 FDA Vote. Wall Street's Average Price Target Says It Should Fall 44%. What Gives?
↗
July 03, 2026
Via
The Motley Fool
Tickers
MRNA
Exposures
COVID-19
Product Safety
HRB Connector Unveils Full-Series Certified PCB Connectors for Automotive, Industrial & Energy Storage Global Markets
July 03, 2026
Via
Get News
Topics
Product Recall
Supply Chain
Exposures
Legal
Product Safety
Supply Chain
Blood-Based Biomarker for Alzheimer's Disease Diagnostics Market Trends Shaping Neurodiagnostics
↗
July 03, 2026
Via
Talk Markets
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.